Yosprala™ (aspirin/omeprazole) – New drug approval
September 14, 2016 – The FDA approved Aralez Pharmaceutical’s Yosprala (aspirin/omeprazole) delayed-release tablets, for patients who require aspirin for secondary prevention of cardiovascular and cerebrovascular events and who are at risk of developing aspirin associated gastric ulcers.
Top